维拉帕米尔是否有效治疗具有鼻息肉的慢性鼻炎患者? 一个系统的审查
Fangxing Yin1, Haris Ali2, Alaa Abdelhalim1
1School of Medicine and Dentistry, Queen Mary University of London, London, UK.
概括
低剂量维拉帕米尔在慢性鼻炎与鼻息肉 (CRSwNP) 方面表现有前途,改善症状. 然而,需要更多的研究来证实它的有效性和指导广泛使用.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 带鼻多的慢性鼻炎 (CRSwNP) 显著影响患者的生活质量.
- 目前对CRSwNP的治疗选择存在局限性,需要探索新型治疗剂.
研究的目的:
- 系统地审查和总结关于低剂量维拉帕米尔在被诊断为CRSwNP的成年患者的疗效的证据.
- 评估维拉帕米尔对CRSwNP主观症状报告和客观临床措施的影响.
主要方法:
- 进行了系统的文献搜索,直到2023年12月28日,确定了三项随机对照试验.
- 在研究选择和数据提取方面遵循了PRISMA指南.
- 主要终点包括生活质量问卷 (例如,SNOT-22) 和客观成像分级 (例如,TNPS,LMS).
主要成果:
- 在116名参与者中,与安慰剂相比,维拉帕米尔显著改善了主观症状得分 (SNOT-22平均差异:19.17和27.7).
- 三项研究中有两项表明,客观指标 (TNPS或LMS) 在统计学上有显著改善.
结论:
- 低剂量维拉帕米尔在CRSwNP的主观和客观测量方面显著改善.
- 目前的证据不足以推广泛使用维拉帕米尔治疗CRSwNP.
- 未来的研究需要更大的样本大小和在方法上强大的,均的研究设计.
相关概念视频
Drugs Used in Upper Respiratory Disorders: Overview
626
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
626
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.3K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.3K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
1.6K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.6K
Upper Respiratory Drugs: Decongestants
823
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
Most decongestants are readily available over-the-counter in...
823
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
932
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
932
Chronic Pharyngitis
10.9K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
10.9K


